Could a cocktail of gut bugs ease IBS diarrhea?
NCT ID NCT07238790
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests whether a mixture of 157 live bacteria from healthy stool, called MITI 001, is safe for people with diarrhea-predominant irritable bowel syndrome (IBS-D). The goal is to restore healthy gut function and ease symptoms. Only 13 adults with specific signs of gut microbiome problems will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIARRHEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford Digestive Health Clinic
Redwood City, California, 94063, United States
-
Stanford University
Stanford, California, 94305, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a postbiotic soothe diarrhea in vulnerable kids?
- School health rooms and trained teachers: a new hope for Zambia's children?
- Could a postbiotic soothe irritable bowel syndrome?
- New Stool-Based care pathway aims to tame diarrhea in ICU patients on tube feeding
- Gut bacteria may hold key to chemo side effects
- Weight-Loss drugs may cause hidden anal issues, new study warns